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Abstract
Fructooligosaccharide (FOS), a prebiotic well known for its health-promoting properties, can improve the
human gut ecosystem most likely through changes in its microbial composition. However, the detailed
mechanism(s) of action of FOS in the modulation of the gut ecosystem remain(s) obscure. Traditional
methods of profiling microbes and metabolites could barely show any significant features due to the exist-
ence of large interindividual differences, but our novel microbe–metabolite correlation approach, com-
bined with faecal immunoglobulin A (IgA) measurements, has revealed that the induction of mucosal IgA
by FOS supplementation correlated with the presence of specific bacteria. Furthermore, the metabolic dy-
namics of butyrate, L-phenylalanine, L-lysine and tyramine were positively correlated with that of these bac-
teria and IgA production, whereas p-cresol was negatively correlated. Taken together, our focused
intraindividual analysis with omics approaches is a powerful strategy for uncovering the gut molecular
network and could provide a new vista for understanding the human gut ecosystem.
Key words: commensal microbiota; correlation analysis; gut ecosystem; metabolite; prebiotics
1. Introduction
Our gastrointestinal tract provides residence to the
intestinal microbiota, which includes both beneficial
and potentially pathogenic microorganisms.1,2 It has
been postulated that an imbalance in the composition
of themicrobiota is a risk factor in several humandisor-
ders, including inflammatory bowel disease, metabolic
syndrome, allergy and cancer.3–5 Furthermore, recent
reports have shown that even minor changes in the
gut microbiome can have an impact on the host
phenotype.6,7 Thus, the ability to shape the intestinal
microbiota should have clinical importance.
The mucosal surface of the intestine is continuously
exposed to an enormous variety of antigens, such as
food antigens and microorganisms. Immunoglobulin A
(IgA) plays important roles in the mucosal immune
system, and it has been shown that the production of
IgA is limited in germ-freemice comparedwith conven-
tional mice.8 In addition, microbial colonization is
required for secretory IgA (SIgA) production in the intes-
tine.9,10 In studiesof gnotobioticmice, itwas shown that
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colonization by microbes, particularly segmented fila-
mentous bacteria, clostridia and Bacteroides species, sti-
mulates production of IgA.11,12 However, it is still
unclear what molecule(s) produced by/derived from
commensalmicrobes induce(s)mucosal IgAproduction.
Prebioticsaredefinedasfood ingredientsthatarenon-
digestible and non-absorbable in the upper gastrointes-
tinal tract and which improve the condition of the host
through selective stimulation of the growth of probiotic
bacteria.13 Fructooligosaccharide (FOS) is a well-known
prebiotic that has anti-tumor,14 infection-protective15
and allergy-preventive effects16 in the host through
host–microbial crosstalk in the gut. The impact of FOS
intake on the intestinal IgA responsehas been extensive-
ly studied inmousemodels. The concentration of IgA in
the small and large intestines is significantly increased
with FOS intake.17 Furthermore, the number of B220þ
IgAþ cells in Peyer’s patches is significantly increased,
and the level of secretory component and SIgA in the
ileal gut lumen is elevated. It has also been shown that
FOS intake enhances production of cytokines, such as
interleukin (IL)-5, IL-6 and interferon-g, in Peyer’s
patches; these cytokines can induce IgA production
through their effects on CD4þ helper T cells, which
further increases the amount of IgA in themucosa.18
In humans, ulcerative colitis patients supplemented
with Bifidobacterium longum and oligofructose-enriched
inulin showed improvement in the clinical features
of chronic inflammation,19 and daily intake of oligo-
fructose and inulin significantly decreased Crohn’s
disease activity.20 Supplementation with FOS has also
been shown to support the growth of Bifidobacterium
species, accompanied by an increase in T lympho-
cytes.21 Some studies have also reported a tendency
for prebiotics-treated individuals to have higher faecal
SIgA levels.22,23 Although commensal microbiota have
been implicated in the FOS-induced production of
IgA, evaluation of the gut microbial ecosystem is not
an easy task, mainly due to its highly complex compos-
ition and the large individual difference among human
subjects.22
We have developed a meta-analysis platform based
on amulti-dimensional profiling technique to evaluate
gut environmental changes, including host–microbial
crosstalk.24 In order to understand the molecular
mechanisms for the induction of IgA production in
human subjects by FOS supplementation through gut
microbes and/or their metabolite(s), we applied the
multivariate microbe–metabolite correlation analysis
combinedwith faecal IgA secretionof thehost to evalu-
ate the inter- and intraindividual changes in the gut
ecosystem occurring with FOS supplementation. Here,
we show a significant correlation of faecal IgA content
with microbial composition and metabolites, and
further implicate the likely involvement of particular
metabolites in FOS-induced IgA secretion.
2. Materials and methods
2.1. Faecal sample collection
Seven volunteers including three males and four
females (20–30 year olds) from different families in
Japan participated in this study (Supplementary Table
S1). All subjects were informed of the purpose of this
study. This study was approved by the ethical commit-
tee of RIKEN, and written consent was obtained from
all subjects. All subjects had no medical history of
gastrointestinal or metabolic diseases, nor had they
had special dietary habits or restrictions, herbal supple-
ments, probiotics or antibiotics within at least 1month
before the sampling. For1week, the volunteers ate FOS,
10 g twice a day (Meioligo W, Meiji Kabusiki Kaisya).
Faecal sampling was performed at least twice during
each period (before FOS intake, during FOS intake and
after FOS intake). Faecal samples from each individual
were immediately frozen on collection and stored at
2808C before analysis.
2.2. Measurement of faecal IgA by enzyme-linked
immunosorbent assay
Faecal samples were lyophilized by using VD-800R
lyophilizer (VD-800R, Tokyo, Japan) for 24 h. Freeze-
dried faeces were ground with 3.0-mm Zirconia Beads
(Biomedical Science, Tokyo, Japan) using a Shake
Master (Biomedical Science) for 10 min. About 10 mg
of faecal samples were measured and suspended into
300 ml of phosphate-buffered saline buffer containing
proteinase inhibitor cocktail tablets: complete EDTA-
free (Roche Applied Science, USA), and homogenized for
1 min. The homogenate was centrifuged at 17,800 g
for 15 min at 48C, and the supernatant was collected
and frozen at 2208C. The amount of faecal IgA was
measured by enzyme-linked immunosorbent assay
(ELISA). To measure total IgA, the wells of a Maxisorp
immunoplate (Nunc, Roskilde, Denmark) were
coated with goat anti-mouse IgA (A90-103A, Bethyl
Laboratories, Inc., USA). After blocking of unoccupied
sites on the plastic with bovine serum albumin, the
test samples and standardmouse IgA (mouse reference
serum; RS10-101, Bethyl Laboratories, Inc.) were
added. Subsequently, bound IgA was detected by se-
quential incubation with horseradish peroxidase-con-
jugated goat anti-mouse IgA antibodies (A90-103P,
Bethyl Laboratories, Inc.) (1 mg/ml), and 3,30,5,50-tet-
ramethyl benzidine (TMB) (OrganonTeknika, Durham,
NC,USA) (1 mg/ml) and1 : 10,000hydrogenperoxide
(H2O2, Wako Pure Chemical Industries, Japan) in
sodium acetate buffer (pH 6.0). After incubation at
room temperature for 15 min, colour development
was stopped by adding 100 ml of 0.18 M sulphuric
acid (H2SO4, Wako Pure Chemical Industries), and
then the absorbance at 450 nm of each well was
Page 2 of 12 Multiple Omics and Host–Gut Microbial Mutualism
 at R
IK
EN
 Y
okoham
a Library on Septem
ber 11, 2014
http://dnaresearch.oxfordjournals.org/
D
ow
nloaded from
 
measured. The total IgA contentof each samplewascal-
culated by means of a standard curve.
2.3. Faecal DNA extraction
About 10 mg of freeze-dried faecal sample was sus-
pended with mixture buffer [400 ml of 10% sodium
dodecyl sulphate (SDS)/10 mM Tris–HCl, 1 mM
EDTA, pH 8.0 solution, 400 ml of phenol/chloroform/
isoamyl alcohol (25 : 24 : 1), and 200 ml of 3 M sodium
acetate]. Faeces in mixture buffer were disrupted with
0.1 mm zirconia/silica beads (BioSpec Products, Inc.,
USA) by vigorous shaking (1500 rpm, for 10 min)
using a Shake Master (Biomedical Science). After
centrifugation at 15,000  g for 30 min at room tem-
perature, the DNAwas purified using a phenol/chloro-
form/isoamyl alcohol (25 : 24 : 1) solution and was
precipitated by adding ethanol and sodium acetate,
and stored at 2208C.
2.4. 454 barcoded pyrosequencing of 16S rRNA gene
TheV1–V2 variable region of the16S rRNA genewas
amplified by PCR using forward primer (50-CCATCTC
ATCCCTGCGTGTCTCCGACTCAGNNNNNNNNNNagrg
tttgatymtggctcag-30) containing the 454 primer A and
reverse primer (50-CCTATCCCCTGTGTGCCTTGGCAGT
CTCAGtgctgcctcccgtaggagt-30) containing the 454
primer B.25 Forward primers were tagged with 10 bp
unique barcode labels at the 50 end along with the
adaptor sequence (indicated in N). Each reaction
mixture contained 10 pmol of each primer, 0.16 mM
deoxyribonucleoside triphosphates, 25 ml of 2xEx Taq
PCR buffer, 1.0 U Ex Taq polymerase (Takara Bio, Inc.,
Shiga), 50 ng extracted DNA and sterilized water to
achieve a final volume of 50 ml. PCR program was set
as follows: 968C 2 min and 20 cycles of 968C 30 s,
558C 45 s, 728C 1 min followed by 728C for 10 min.
After confirmation of the PCR product formation
using agarose gel electrophoresis, purified by AMPure
XP magnetic purification beads (Beckman Coulter,
Inc., Brea, CA, USA), and quantified using the Quant-iT
PicoGreen ds DNA Assay Kit (Life Technologies Japan,
Ltd, Tokyo, Japan). Mixed samples were prepared
by pooling approximately equal amounts of PCR
amplicons from each sample and subjected to 454 GS
FLX Titanium or 454 GS JUNIOR (Roche Applied
Science) sequencing according to the manufacturer’s
instructions.
2.5. Analysis of 16S rRNA sequences using the
QIIME pipeline
16S rRNA sequencedatawere processed by thequan-
titative insights into microbial ecology (QIIME) pipe-
line.26 Briefly, sequences that were less than 200 bp or
greater than 1000 bp in length contained incorrect
primer sequences, orcontainedmore than2ambiguous
bases were discarded. The remaining sequences were
assigned sample aliquots basedon their uniquenucleo-
tide barcodes, including error-correction. Chimeric
sequences were removed using Usearch.27 Reads
removed in these filters were 42% of all sequences
(Supplementary Table S2). All filter-passed reads of
the 16S V1–2 sequences were deposited in DDBJ with
accession number DRA001212. Sequences were clus-
tered into Operational Taxonomic Units (OTUs) using
97% sequence similarity. OTUs were assigned to a tax-
onomy using RDP classifier with the confidence level
set at 0.5.28
2.6. Sample extraction for NMR measurements
Faecal samples (10 mg) were measured and sus-
pended with extraction buffer consisting of 90% (v/v)
deuterium oxide (D2O), 100 mMpotassium phosphate
and 1 mM 2,2-dimethyl-2-silapentane-5-sulphonate
(DSS) as an internal standard. The solution was shaken
at 1500 g for 15 min at 658C and then centrifuged
at 15,000  g for 15 min at 48C. The supernatant was
collected in an NMR tube and frozen at 2208C.29
2.7. 1D and 2D NMR measurements
All NMR spectrawere recorded on a Bruker DRX-700
spectrometer operating at 1H700.153 MHz frequency
with the temperature of the NMR samples maintained
at 298 K. The NMR spectra were processed using a
procedure similar to that described previously.30–33
Briefly, 1H NMR data were reduced by subdividing
spectra into sequential bins of 0.04 ppm designated
regions between 1H chemical shifts of 0.06–9.8 ppm.
1H-13C heteronuclear single quantum coherence
(HSQC) data were reduced by subdividing spectra into
sequential bins of 0.3 ppm in the f1 direction and
0.03 ppm in f2 designated regions between 1H chem-
ical shifts of 0.5–9.0 ppm and 13C chemical shifts of
40–90 ppm, respectively. After exclusion of water res-
onance, each region was integrated and normalized
relative to the DSS intensity and analysed by principal
component analysis (PCA) using the R software and
plotted using the Excel software. Loading plot analysis
revealed the contribution of bins to the PCA scores,
and 2D spectral assignments were performed using
the SpinAssign software.33
2.8. Multivariate statistical analysis
Supplementary Figure S1 provides a schematic over-
view of the analytical steps in this study. Multivariate
statistical analysiswasperformedwithRprogramenvir-
onment by using an in-house program. A two-dimen-
sional correlation map was calculated as a symmetric
matrix using Spearman’s rank correlation coefficient,
in which an element at position (i, j) is defined as a cor-
relation coefficient between the ith and jth positions in
T. Kato et al. Page 3 of 12
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each set of 1D spectra of metabolites, microbial diver-
sity of high-throughput sequencing and the amount
of IgA. A more positive (negative) coefficient means
the existence of a positive (negative) correlation
between the ith and jth peaks or bands. Each cor-
relation pattern was clustered using hierarchical clus-
tering analysis (HCA). HCA was performed using a
Euclidean distance and ward clustering method. The
two-dimensional correlation map was drawn by the R
software.29
In the heat map of microbe–metabolite correlation
coefficient, individual ID number was put as a tag in
front of each microbe name (at the family level) to
clarify the individual from whom those microbes were
isolated (for example, ID4-Bacteroidaceae). Correlation
coefficient between microbial composition and meta-
bolic profile was calculated in each individual, and the
data obtained from individuals weremerged. Microbe–
metabolite correlation patternwas clusteredusingHCA.
HCA of the metabolic profiles in individual ID-coded
microbes reveals several metabolic profile clusters that
were related to differentmicrobes. Clusters ofmetabolic
profiles defined by cutting branches off the dendrogram.
Weselectedclusters inwhichmorethan70%ofmicrobes
were derived from IgA responders ID4 and ID5.
IgA–metabolite–microbe correlation network was
constructed with microbes in extracted clusters, based
on the multiple correlation data from ID4 and ID5
using the Cytoscape software34 (http://www.cytoscape.
org/). Each node indicated IgA, a metabolite and a
microbe from the result of the above analysis.
Microbial node size showed theaveragevalueof relative
abundance. Edges represent the correlation coefficient
.0.65 between the two connected nodes in the
network. Width of each edge line positively correlates
with its correlation coefficient value.
3. Results and discussion
3.1. FOS effect on faecal IgA concentration is
heterogeneous in different healthy
human volunteers
Faecal samples were collected at several time points
from healthy volunteers (age ¼ 20–30, male ¼ 3,
female ¼ 4) before, during and after FOS intake, and
the amount of faecal IgA was determined. As a group,
the average faecal IgA tended to increase upon FOS
intake,butthedifferencewasnot statisticallysignificant
(Fig. 1A). However, the individual faecal IgA profiles
were quite heterogeneous (Fig. 1B and Supplementary
Fig. S2); especially, only in volunteers ID4 and ID5, the
faecal IgA levels were significantly elevated during the
FOS-intake period when compared with those in
other periods. Therefore, the effect of FOS on IgA induc-
tion varies widely among individuals.
Several studies have reported that FOS increasesbene-
ficial bacteria such as Bifidobacterium, thereby stimulat-
ing the host immune system in humans.35 Another
report has showna trend toward higher SIgA concentra-
tions following intake of a galactooligosaccharide/FOS
mixture, albeit with large interindividual variations.22
3.2. Commensal microbiota composition varies
greatly among individuals
We hypothesized that the effect of FOS intake on
faecal IgA levels was likely influenced by individual dif-
ferences in the composition of the gut microbiota. To
Figure 1. Effect of FOS supplementation on total faecal IgA production in human volunteers. (A) The average levels of faecal IgA in all seven
volunteers before, during and after FOS supplementation. NS, no significant difference. (B) The individual average amounts of faecal IgA
before, during and after FOS supplementation. Faecal sampling was performed at least twice during each period. P-values between FOS
supplementation period and other periods were determined using the non-parametric Mann–Whitney U-test. *P, 0.1; **P, 0.01.
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determine whether this was the case, PCR products of
bacterial 16S rRNA-encoding genes in the faecal DNA
samples were analysed using high-throughput pyrose-
quencing. A total of 222,863 reads were sequenced,
averaging at 3537 reads per sample. Indeed, the heat
maps of the individual microbial profiles at the family
level looked quite different from each other (Fig. 2A).
Consistently, the unweighted UniFrac PCoA of faecal
microbiota clustered the faecal DNA samples from
the same individuals (Fig. 2B), rather than from the
samples with and without FOS intake (Fig. 2C), indicat-
ing that FOS-induced microbiota variations are over-
looked because of the large interindividual variations
when datasets from individuals are collectively ana-
lysed (Fig. 2D and Supplementary Fig. S3).
Our observations are consistent with a number of
studies reporting individual differences in the structure
of gutmicrobiota. Threehumanenterotypes canbedis-
tinguished by differences in microbial composition.36
These enterotypes are not altered by short-term diet
changes.37 Consistent with this stability, FOS did not
alter the major composition of the intestinal micro-
biota in individuals in this study (Fig. 2B and C).
3.3. Faecal metabolic profiles are distinctive
among individuals
Wealso examined the individual faecalmetabolic pro-
files before, during and after FOS intake, since prebiotic
FOS-induced metabolic changes in the gut ecosystem
could result in the modification of IgA production. To
Figure 2. Effect of FOS supplementation on the humanmicrobiome. (A) Heatmap profiles of individual gut microbiomewere analysed at the
microbial family level. These profileswerenormalized to a relative valuebetween0and1. (B) and (C) PCoA onUniFrac distancematrix from
all volunteers before, during and after FOS supplementation. PCoA plots are coloured by individuals (B) and shaded by diet periods (C). (D)
The comparison of Unifrac distance between intra- and interindividuals. P-values were determined using theMann–WhitneyU-test. **P,
0.01.
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this end, faecal metabolites were extracted from the
faecal samples and measured by 1H NMR spectroscopy.
The heat map of the obtained 1H NMR spectra divided
into bins showed similar interindividual metabolic
changes upon FOS intake (Fig. 3A). Nevertheless, the
PCA of these metabolic profiles showed a tendency
towards individual clustering (Fig. 3B), rather than
being clustered according to the presence or absence
of the FOS supplementation (Fig. 3C). These observa-
tions are consistent with a previous study, reporting
that 1H NMR-based metabolomics of urine and serum
show individual differences.38,39
Taken togetherwith the data onmicrobiota compos-
itiondescribedabove (Fig. 2), these results indicate that
interindividual differences are too large for population
analyses such as PCA to extract significant parameters
contributing to the FOS-induced differences, and that
intraindividual analysis could instead reveal the
mechanisms for the effect of FOS on IgA production in
humans. Thus, the individual difference in the effect
of FOS on faecal IgA concentration could be due to the
individual differences in their gut microbiota and/or
metabolites.
3.4. Intraindividual correlation analyses among
commensal microbiota composition, faecal
metabolic profiles and faecal IgA concentration
reveal microbial and metabolic changes related
to enhanced faecal IgA levels
Toevaluate intraindividually the impactofFOS intake
on gut microbiota composition in the absence of the
interindividual differences, we performed individual
PCA (Supplementary Fig. S4A). The data revealed that
Figure3. EffectofFOSsupplementationonfaecalmetabolites. (A)Heatmapprofilesof individualmetabolomes inthistrial. Faecalmetabolome
profilingwas performed by 1HNMRand the profileswere normalized to a relative value between0 and 1. (B) and (C) Principal component
analysis on faecal metabolome data from all volunteers before, during and after FOS supplementation. Score plots are coloured by
individuals (B) and shaded by diet periods (C).
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FOS intake caused changes in microbiota composition
ineach individual, but that thesechangesweredifferent
from individual to individual. We also evaluated the in-
fluenceof FOS intakeon the individual faecalmetabolic
profile, byperformingPCA individually (Supplementary
Fig. S4B). Similar to the changes observed in themicro-
biota, FOS also induced faecal metabolic changes in
each individual.
Inorder toobtainmore integrated informationabout
the effect of FOS intake on IgA production, we next
performed intraindividual two-dimensional correl-
ation analyses to link the commensal microbial vari-
ation, the faecal metabolic profile and the amount of
faecal IgA. The coefficient of correlation for each indi-
vidual gut environmental factor was calculated using
the Spearman’s rank correlation coefficient, and the
correlative information was clustered individually by
HCA to seek the covariation factor(s) that related to
the induction of faecal IgA production (Fig. 4). The
microbe–IgA correlation analysis showed that the
Figure 4. Individual ecological dynamics in the gut during FOS supplementation. (A) Correlation coefficients between faecal IgA–microbiome
profile and (B) faecal IgA–faecalmetabolomewere calculatedby Spearman’s rank correlation coefficientusing theR software (http://www.
r-project.org/). A correlationmatrix is represented by negative correlation (R , 20.65; blue) and positive correlation (R. 0.65; red). The
correlation similarity among individuals was further clustered by HCA.
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commensalmicrobiota composition co-varied strongly
with the individual faecal IgA production profile
(Fig. 4A). HCA on themicrobe–IgA correlation patterns
from seven volunteers showed that the profile from ID3
and ID7 was strikingly distinct from the others. This
might result from an apparently abnormal IgA profile
in ID3 in that the faecal IgA levels were extremely low
during and after FOS intake (Supplementary Fig. S2).
In addition,microbiotacomposition in ID7 is adifferent
from the other individuals (Fig. 2B). In themetabolite–
IgA correlation analysis, we found that the correlation
patterns were divided into two groups; ID4 and ID5
were grouped together and separated from the others
(Fig. 4B). As described above, the amount of IgA was
significantly increased during FOS intake only in ID4
and ID5, suggesting that the change in metabolites
common to ID4 and ID5, but not to the other indivi-
duals, may contribute to their FOS-induced increase
in faecal IgA. 1H chemical shifts revealed by this analy-
sis to be common in ID4 and ID5 are listed in
Supplementary Table S3.
To analyse the relationship between microbiota and
faecal metabolites before, during and after FOS intake,
we performed microbe–metabolite correlation ana-
lysis (Fig. 5A). Characteristic correlation patterns were
represented as the phenolic region (around 6.5–
8.5 ppm). Based on the HCA, the correlation patterns
divided the microbiota into 11 bacterial clusters.
Faecal bacteria fromeach individual contributeddiffer-
ently to these clusters (Fig. 5B); intriguingly, Clusters 1,
6 and 8 consisted of the microbes derived predomin-
antly from ID4and ID5 (.70%). The result showed that
these microbes were closely related to Rikenellaceae,
Bifidobacteriaceae, S24-7, Peptostreptococcaceae,
Barnesiellaceae, Mogibacteriaceae, Pasteurellaceae,
Veillonelaceae, Coriobacteriaceae, Clostridiaceae,
Alcaligenaceae, Desulfovibrionaceae and Pasteurellaceae
at the family level (Supplementary Table S3). Major
OTUs in these microbial families were assigned using
BLAST against non-redundant database (Supplementary
Table S4). SupplementaryTable S3 lists the 1Hchemical
shifts of metabolites correlated with these clusters
which were commonly seen in ID4 and ID5.
3.5. Assignment of the candidate metabolites involved
in the induction of faecal IgA production
Comparison of metabolites correlated with IgA and
microbes shared in ID4 and ID5 (Supplementary Table
S3) revealed that some of the 1H chemical shifts were
Figure 5. Identificationof the gutmicrobes correlatedwith faecal IgA inductionby FOS supplementation. (A)Correlation coefficients between
gutmicrobiome–faecal metabolomewere calculated by Spearman’s rank correlation coefficient. The 11 clusters based on the correlation
similarityamongmicrobes (thecut-offheightof30,whichwasdeterminedsothatthenumberof leafnodes inacluster isover10, shownasa
dotted line) were further clustered by HCA. (B) Composition of the individually derived microbes in each cluster.
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commonlyextractedfromboththemicrobe–metabolite
correlation and the metabolite–IgA correlation. These
metabolites were assigned by two-dimensional J-
resolved (2D-J) spectroscopy, 1H-13C HSQC and total
correlation spectroscopy (TOCSY),40 as well as accord-
ing to the literature41–43 and the PRIME website44
(Supplementary Table S5). Metabolites that showed a
positive correlation with increased IgA were identified
as L-phenylalanine (3.30 and 7.42 ppm), L-lysine
(1.70 and3.02 ppm), tyramine (6.90 ppm) andbutyr-
ate (2.14 ppm); and p-cresol (6.82 and7.10 ppm)was
negatively correlated with IgA levels. The molecular
network around IgA based on these results is shown in
Fig. 6. Taken together, our results suggest that these
bacteria in clusters are directly or indirectly involved
in the metabolism of these molecules, an activity that
may ultimately result in the up-regulation of faecal
IgA production in the gut of ID4 and ID5.
In this study, a positive correlation of L-lysine, L-
phenylalanine, tyramine and butyrate, and a negative
correlation of p-cresol, were found with the FOS
intake-induced increase in faecal IgA, using the com-
bination of microbe–metabolite and metabolite–IgA
correlation analyses (Fig. 6). Consistent with our obser-
vations, it has been reported using in vitro experiments
that human intestinal contents with live commensal
Figure 6. Molecular network of the gut ecosystem supplemented with FOS. This network was constructed based on the multiple correlation
data from ID4 and ID5 using the Cytoscape software34 (http://www.cytoscape.org/). Green rectangles, blue spheres and purple hexagon
indicate metabolites, microbes and IgA, respectively. Sphere size of microbial nodes corresponds to their average relative abundance.
Positive and negative correlations are shown as green and red lines, respectively. Purple and blue circles indicate metabolites and
microbes, respectively, which highly correlate with faecal IgA abundance. Metabolite a: L-lysine, b: butyrate, c: L-phenylalanine, d:
tyramine, e: p-cresol. Microbe 1: ID4 Rikenellaceae, 2: ID5 Bifidobacteriaceae, S24-7, 3: ID5 Peptostreptococcaceae, 4: ID4
Barnesiellaceae, Mogibacteriaceae, Pasteurellaceae and ID5 Clostridiaceae, 5: ID4 Veillonelaceae, Coriobacteriaceae, 6: ID5
Pasteurellaceae, 7:ID5 Desulfovibrionaceae.
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microbesmetabolize FOS into butyrate and tyramine.45
Bifidobacterium preferentially utilize FOS as an energy
source to produce lactate and acetate. Bifidobacterium
themselves do not generally produce butyrate,46 but
other commensal microbes can produce butyrate from
acetate and lactate produced by Bifidobacterium.47,48 It
has also been reported that both lactate and acetate
can be converted to butyrate by human faecalmicrobes
in vitro.49
Tyramine is a decarboxylation product of tyrosine,
and two types of tyrosine metabolic pathways exist in
commensal microbes. One pathway produces p-
cresol,35,50 while the other produces tyramine.51,52
Our data showed that tyramine and p-cresol were posi-
tivelyandnegatively correlatedwith IgA production, re-
spectively, in FOS responders ID4 and ID5, suggesting
that FOS intake may impact the microbiota compos-
ition to change the tyrosine metabolic pathways in
favour of tyramine production in the gut ecosystem of
FOS responders.
It has been reported that an important function of
phenylalanine is to up-regulate the expression of GTP
cyclohydrolase I, which is the first and rate-controlling
enzyme for the synthesis of tetrahydrobiopterin, an es-
sential cofactor for nitric oxide synthase (NOS).
Consequently, an adequate intake of dietary phenyl-
alanine is required to maintain a sufficient provision
of tetrahydrobiopterin for the production of NO by in-
ducible NOS (iNOS) in activated macrophages and
other leucocytes.53 Moreover, an inadequate intake of
dietary lysine reduces antibody responses and cell-
mediated immunity.54 By sharing the same transport
systems with arginine, the availability of dietary or
extracellular lysine can modulate the entry of arginine
into leucocytes and NO synthesis by iNOS.53 iNOS is
expressed mainly in macrophages and dendritic cells,
which produce NO upon stimulation with cytokines
and bacterial components. Recent investigations have
demonstrated that IgA production is decreased in
iNOS2/2 mice.55 Therefore, these amino acids may be
involved in the induction of IgA production through
NO production.
3.6. Conclusion
In the present study, our intraindividual, multiple
time point correlation analyses showed that enhance-
ment of faecal IgA levels by FOS supplementation corre-
lates with changes in the intestinal metabolites, likely
produced by commensal microbes. Our study also
have confirmed that the human intestinal microbiota
possess large individual variations thatmake it difficult
to detect significant but small changes commonly
induced in individuals by an intervention, such as FOS
intake in this study. This fact emphasizes the import-
ance of intraindividual analyses, such as those
employed in our study, for analysing changes in the
gut microbiota in the human population. Consistent
with this notion, a similar approach has recently been
taken to reveal human gut environmental changes
in response to short-term dietary intervention.56
Collectively, we propose that the multiple omics ap-
proach on the repeated intraindividual time-course
sampling should be appropriate for uncovering the
gut environmental changes upon intake of probiotics
and prebiotics, as well as foods and drugs. In contrast,
when repeated intraindividual samples are not avail-
able, these approaches may not detect significant
differences/changes unless data from a large scale
population are collected.
In conclusion, our study has demonstrated that
intraindividual multiple time-point correlation ana-
lyses are useful for understanding the FOS intake-
induced increase in faecal IgA concentration. Since an
enormous amount of biological data can be obtained
with recent innovations in analytical hardware, such
as the pyrosequencer, NMR and mass spectrometry,
data-mining techniques are becoming more and
more important. Application of our multiple correl-
ation approach for analysing the individual gut ecosys-
tems will enable us to better understand the whole
picture of the impact of prebiotics, such as FOS andpro-
biotics, on our gut ecosystem.
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